We are live on ! Find out more
NPA

Nichols & Pratt Advisers Portfolio holdings

AUM $1.65B
1-Year Est. Return 22.9%
This Fund
S&P 500
This Quarter Est. Return
+1.78%
1 Year Est. Return
+22.9%
3 Year Est. Return
+58.88%
5 Year Est. Return
+87.69%
10 Year Est. Return
+260.41%
AUM
$1.48B
AUM Growth
-$4.9M
Cap. Flow
-$12.2M
Cap. Flow %
-0.83%
Top 10 Hldgs %
51.78%
Holding
106
New
4
Increased
15
Reduced
58
Closed
9

Top Buys

Rank Stock Value
1
RTO icon
Rentokil
RTO
+$1.37M
2
GPN icon
Global Payments
GPN
+$860K
3
IQV icon
IQVIA
IQV
+$823K
4
TMO icon
Thermo Fisher Scientific
TMO
+$822K
5
GEV icon
GE Vernova
GEV
+$756K

Top Sells

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$1.64M
2
PG icon
Procter & Gamble
PG
+$1.53M
3
MMM icon
3M
MMM
+$1.34M
4
MSFT icon
Microsoft
MSFT
+$1.28M
5
GE icon
GE Aerospace
GE
+$1.17M

Sector Composition

Rank Sector Weight
1 Technology 30.91%
2 Healthcare 21.26%
3 Consumer Staples 11.17%
4 Communication Services 8.13%
5 Industrials 7.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CTVA icon
101
Corteva
CTVA
$51.3B
-3,517
Closed -$203K
DE icon
102
Deere & Co
DE
$168B
-625
Closed -$257K
EFA icon
103
iShares MSCI EAFE ETF
EFA
$80.2B
-3,403
Closed -$272K
EL icon
104
Estee Lauder
EL
$32B
-2,012
Closed -$310K
GWW icon
105
W.W. Grainger
GWW
$60.2B
-211
Closed -$215K
PHR icon
106
Phreesia
PHR
$773M
-12,365
Closed -$296K

Similar funds

Nichols & Pratt Advisers's Q2 2024 Portfolio in Review

As of Q2 2024, Nichols & Pratt Advisers held 106 positions worth $1.48B, down 0.33% from $1.48B the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Nichols & Pratt Advisers's Q2 2024 filing shows 4 new, 15 increased, 58 reduced and 9 closed positions. Its largest new stake was GE Vernova: 4,773 shares worth $819K. The largest sale was CVS Health, an estimated $1.64M.

By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 30% a quarter earlier, followed by Healthcare and Consumer Staples.

  • Nichols & Pratt Advisers's largest Q2 2024 buy was GE Vernova: 4,773 shares worth $819K.
  • Nichols & Pratt Advisers added most to Rentokil in Q2 2024, an estimated $1.37M increase.
  • Nichols & Pratt Advisers's biggest Q2 2024 reduction was CVS Health, cutting an estimated $1.64M.
  • Nichols & Pratt Advisers fully exited Estee Lauder in Q2 2024, selling an estimated $310K.
  • Nichols & Pratt Advisers's ten largest holdings make up 52% of its $1.48B portfolio in Q2 2024.
  • Nichols & Pratt Advisers opened 4 new positions and closed 9 in Q2 2024.
  • Nichols & Pratt Advisers's portfolio value fell 0.33% quarter-over-quarter to $1.48B.

Based on Nichols & Pratt Advisers's 13F filing for Q2 2024, filed 25 Jul 2024.